Virtual Kol Event: RZ402 - An Oral Plasma Kallikrein Inhibitor for DME - Wednesday, March 22, 2023 at 4:30 PM Edt

Learn More »

Plasma Kallikrein Mediates Angiotensin II Type 1 Receptor–Stimulated Retinal Vascular Permeability

Back to Careers